Curaleaf Holdings Inc. (C:CURA)
Business Focus: Recreational Pharmaceuticals
Mostly sunny as of September 01, 2023
For the latest outlook, get the company report
You may also be interested in
Insider Filings
Latest 10 SEDI filings for CURA within the last 6 months
See all filings within the past 6 months
Read full article
Read full article
See more news stories
See all valuations
See Short Report
Loading...
Company News
Sep 05, 2023 08:00 ET
Curaleaf Expands Brand Portfolio With Launch of Zero Proof ™ Cannabis-Infused Drinkables
Zero Proof's inaugural product offering, Squeeze, delivers fast-acting line of THC beverage enhancers in a sessionable and easy-to-use format
Aug 30, 2023 12:24 ET
Canadian Investment Regulatory Organization Trading Halt - CURA
VANCOUVER, BC, Aug. 30, 2023 /CNW/ - The following issues have been halted by CIRO:
Valuation Ratios
Industry
Sector
Beta
1.67
--
--
Price to Sales - TTM
2.11
0.86
2.84
Price to Book - most recent quarter
2.48
1.57
1.80
Price to Cash Flow per share - TTM
--
--
11.64
Price to Free Cash Flow per share - TTM
--
0.55
12.35
Short Report
| Date | Number of Shares Shorted | Net Change |
|---|---|---|
| Sep 15, 2023 | 888,608 | 482,550 |
| Aug 31, 2023 | 406,058 | 11,953 |
| Aug 15, 2023 | 394,105 | -66,545 |
Business Summary
| Sector: Healthcare | Industry: Pharmaceuticals |
Curaleaf Holdings, Inc. is a Canada-based international provider of consumer products in cannabis. The Company and its brands, including Curaleaf, Select, and Grassroots provide service, product selection and accessibility across the medical and adult-use markets. It operates in approximately 19 states and owns and operates 152 dispensaries and 22 cultivation sites with a focus on states, including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York, and Pennsylvania. Curaleaf International is the vertically integrated cannabis company in Europe with a supply and distribution network throughout the European market, bringing together science and research with cultivation, extraction and production. Curaleaf is the national retail dispensary brand in the United States and a mainstream cannabis brand available in multiple states and product formats: Vape Oils & Concentrates, Flower, Prerolls & Flower Pods, Topical Lotions, Capsules & Tinctures, Mints & Lozenges and Edibles.
See business summary
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
US Quotes Data provided by IEX. Additional price data powered by Twelve Data. Company fundamental sourced from © Refinitiv. Click for restrictions. © Refinitiv. All rights reserved. Republication or redistribution of Refinitiv, including by framing or similar means, is prohibited without the prior written consent of Refinitiv. Refinitiv is not liable for any errors or delays in Refinitiv content, or for any actions taken in reliance on such content.
Interactive technical study charts by TradingView. Copyright © 2023 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.